Lung cancer vaccines and gene therapy (Q35179439)

7 August 2017

1 reference

title

Lung cancer vaccines and gene therapy (English)

1 reference

7 August 2017

0 references

1 reference

Kristen M Hege

1

1 reference

7 August 2017

David P Carbone

series ordinal

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

41 Suppl 1

1 reference

7 August 2017

page(s)

S103-13

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Filamentous particles in human alveolar cell carcinomas: electron microscopy studies of six cases (preliminary report)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Expression of the melanoma antigen-encoding gene in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Cytokine gene therapy or infusion as treatment for solid human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Clinical update of Ad-p53 gene therapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

The role of the bystander effect in suicide gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Antiangiogenic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

MEK kinase activity is not necessary for Raf-1 function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900153-3

7 January 2021

10.1016/S0169-5002(03)00153-3

Identifiers

DOI

1 reference

7 August 2017

1 reference